Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?
ImmunoTargets and Therapy, December 2013
Rakez Kayed, Diana Castillo-Carranza, Marcos Guerrero-Muñoz
The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.
|Practitioners (doctors, other healthcare professionals)||1||100%|
The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.
|Readers by professional status||Count||As %|
|Student > Master||5||19%|
|Student > Bachelor||3||12%|
|Student > Postgraduate||3||12%|
|Student > Ph. D. Student||2||8%|
|Readers by discipline||Count||As %|
|Agricultural and Biological Sciences||5||19%|
|Biochemistry, Genetics and Molecular Biology||5||19%|
|Medicine and Dentistry||4||15%|